Leukocytosis a nd t he R etinoic A cid S yndrome i n P atients With A cute P romyelocytic L eukemia T reated W ith A rsenic Trioxide
暂无分享,去创建一个
S. Soignet | D. Scheinberg | R. Warrell | L. Camacho | G. Heller | R. Ho | S. Chanel | R. Ellison
[1] J. Jansen,et al. Dexamethasone does not counteract the response of acute promyelocytic leukaemia cells to all‐trans retinoic acid , 1999, British journal of haematology.
[2] C. Ho,et al. In vitro effect of granulocyte‐colony stimulating factor and all‐trans retinoic acid on the expression of inflammatory cytokines and adhesion molecules in acute promyelocytic leukemic cells , 1999, European journal of haematology.
[3] P. Pandolfi,et al. Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide , 2001 .
[4] J. Miguel,et al. Incidence, Clinical Features, and Outcome of AllTrans-Retinoic Acid Syndrome in 413 Cases of Newly Diagnosed Acute Promyelocytic Leukemia , 1998 .
[5] C. Peschle,et al. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. , 1998, Journal of the National Cancer Institute.
[6] C. Bloomfield,et al. All-trans-retinoic acid in acute promyelocytic leukemia. , 1997, The New England journal of medicine.
[7] Wei Tang,et al. Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. , 1997, Blood.
[8] T. Barbui,et al. Effect of all trans‐retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells , 1997, International journal of cancer.
[9] F. Mandelli,et al. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study. , 1996, Blood.
[10] T. Barbui,et al. All‐trans‐RETINOIC ACID INCREASES ADHESION TO ENDOTHELIUM OF THE HUMAN PROMYELOCYTIC LEUKAEMIA CELL LINE NB4 , 1996, British journal of haematology.
[11] S. Ziegler,et al. Modulation of human G‐CSF receptor mRNA and protein in normal and leukemic myeloid cells by G‐CSF and retinoic acid , 1995, Journal of leukocyte biology.
[12] J. Wiley,et al. Reduction of pulmonary toxicity by prednisolone prophylaxis during all-trans retinoic acid treatment of acute promyelocytic leukemia. Australian Leukaemia Study Group. , 1995, Leukemia.
[13] A. Falanga,et al. Effects of dexamethasone on pro-inflammatory cytokine expression, cell growth and maturation during granulocytic differentiation of acute promyelocytic leukemia cells. , 1995, European cytokine network.
[14] M. Tanimoto,et al. All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group. , 1995, Blood.
[15] R. Manfredini,et al. All-trans-retinoic acid induces simultaneously granulocytic differentiation and expression of inflammatory cytokines in HL-60 cells. , 1995, Experimental hematology.
[16] P. Maslak,et al. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. , 1994, Blood.
[17] M. Toubert,et al. Induction of high-affinity GM-CSF receptors during all-trans retinoic acid treatment of acute promyelocytic leukemia. , 1994, Leukemia.
[18] P. Fenaux,et al. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. , 1994, Leukemia.
[19] E. Schiavone,et al. All‐trans retinoic acid promotes a differential regulation of adhesion molecules on acute myeloid leukaemia blast cells , 1994, British journal of haematology.
[20] A. Vaheri,et al. Activation of interleukin-1 beta gene expression during retinoic acid-induced granulocytic differentiation of promyeloid leukemia cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[21] D. Adams,et al. Leucocyte-endothelial interactions and regulation of leucocyte migration , 1994, The Lancet.
[22] E. Dmitrovsky,et al. All-trans Retinoic Acid for Acute Promyelocytic Leukemia: Results of the New York Study , 1994, Annals of Internal Medicine.
[23] J. Szer,et al. Cytokine priming of acute myeloid leukemia may produce a pulmonary syndrome when associated with a rapid increase in peripheral blood myeloblasts. , 1993, Blood.
[24] T. Horie,et al. [A "retinoic acid syndrome" observed in two cases of acute promyelocytic leukemia]. , 1993, [Rinsho ketsueki] The Japanese journal of clinical hematology.
[25] W. Hwang,et al. Treatment of acute promyelocytic leukemia with all‐trans retinoic acid: Successful control of hyperleukocytosis and leukostasis syndrome with leukaphereses and hydroxyurea , 1993, American journal of hematology.
[26] R. Warrell,et al. Acute promyelocytic leukemia. , 1993, The New England journal of medicine.
[27] N. Chanarin,et al. Retinoic acid syndrome , 1993, The Lancet.
[28] R. Warrell. Fatal All-Trans Retinoic Acid Pneumonitis , 1993 .
[29] R. Strieter,et al. Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups , 1993, The Lancet.
[30] H. Dombret,et al. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage. , 1992, Leukemia.
[31] R. Warrell,et al. The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia , 1992, Annals of Internal Medicine.
[32] S. Suter,et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. , 1992, The American review of respiratory disease.
[33] E. Dmitrovsky,et al. Reverse transcription polymerase chain reaction for the rearranged retinoic acid receptor alpha clarifies diagnosis and detects minimal residual disease in acute promyelocytic leukemia. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[34] A. Huber,et al. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. , 1991, Science.
[35] Zi X. Chen,et al. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. , 1991, Blood.
[36] E. Dmitrovsky,et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). , 1991, The New England journal of medicine.
[37] R Berger,et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. , 1990, Blood.
[38] Zhen-yi Wang,et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.
[39] S. Soignet,et al. All-trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study , 1997, Cancer Chemotherapy and Pharmacology.
[40] P. Zhang,et al. Arsenic trioxide treated 72 cases of acute promyelocytic leukemia , 1996 .
[41] T. Naoe,et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. , 1996, Blood.
[42] E. Schiavone,et al. Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia. , 1994, Leukemia.
[43] S. Collins,et al. Identification and sequence analysis of the promoter for the leukocyte integrin beta-subunit (CD18): a retinoic acid-inducible gene. , 1992, Blood.
[44] L. Degos. [All-trans-retinoic acid in the treatment of acute promyelocytic leukemia]. , 1990, Presse medicale.